BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1380230)

  • 1. Macrophages in melanocytic naevi.
    Bröcker EB; Reckenfeld C; Hamm H; Ruiter DJ; Sorg C
    Arch Dermatol Res; 1992; 284(3):127-31. PubMed ID: 1380230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple agminate Spitz naevi: review of the literature and report of a case with distinctive immunohistological features.
    Hamm H; Happle R; Bröcker EB
    Br J Dermatol; 1987 Oct; 117(4):511-22. PubMed ID: 3314974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micro-anatomy related antigen expression in melanocytic lesions.
    Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
    J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of HLA-Dr and CD1+ cells in malignant and benign pigmentary tumors].
    Ramírez-Bosca A; Valcuende-Cavero F; Rufat-Pérez MJ; Castells-Rodellas A
    Med Cutan Ibero Lat Am; 1989; 17(1):58-64. PubMed ID: 2474114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased density of epidermal dendritic cells in melanocytic naevi: the possible role of in vivo sun exposure.
    Azizi E; Schwaaf A; Lazarov A; Shifer O; Lublin A; Pavlotsky F; Trau H; Lusky A; Topaz M; Engelberg S; Broecker EB
    Melanoma Res; 1999 Oct; 9(5):521-7. PubMed ID: 10596919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative activity of cutaneous melanocytic neoplasms defined by a proliferating cell nuclear antigen labelling index.
    Tokuda Y; Mukai K; Matsuno Y; Furuya S; Shimosato Y; Takasaki Y; Saida T; Ishihara K
    Arch Dermatol Res; 1992; 284(6):319-23. PubMed ID: 1363460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
    J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory cell infiltrates in human melanoma at different stages of tumor progression.
    Bröcker EB; Zwadlo G; Holzmann B; Macher E; Sorg C
    Int J Cancer; 1988 Apr; 41(4):562-7. PubMed ID: 3128489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The carcinoembryonic antigen (CEA) family (CD66) expressed in melanocytic naevi is not expressed in blue naevuscell naevi in dendritic type.
    Egawa K; Honda Y; Kuroki M; Ono T
    J Cutan Pathol; 2000 Aug; 27(7):351-8. PubMed ID: 10917162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanocytic naevi clustered on normal background skin.
    Torchia D
    Clin Exp Dermatol; 2015 Apr; 40(3):231-7. PubMed ID: 25703021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nevus associated malignant melanomas--diagnostic validation and prognosis].
    Stadler R; Garbe C
    Hautarzt; 1991 Jul; 42(7):424-9. PubMed ID: 1938395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can HLA-DR expression help in the routine diagnosis of malignant melanomas?
    West KP; Priyakumar P; Jagjivan R; Colloby PS
    Br J Dermatol; 1989 Aug; 121(2):175-8. PubMed ID: 2775642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoplasmic beta-catenin is lacking in a subset of melanoma-associated naevi, but is detectable in naevus-associated melanomas: potential implications for melanoma tumorigenesis?
    De Panfilis G; Ferrari D; Santoro S; Ricci R; Lombardi M; Pedrazzi G; Pepe C; Cortelazzi C; Santini M
    Br J Dermatol; 2009 Mar; 160(3):600-8. PubMed ID: 19183173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
    Fröhlich E; Mack AF; Garbe C; Klessen C
    Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infiltration of primary and metastatic melanomas with macrophages of the 25F9-positive phenotype.
    Bröcker EB; Zwadlo G; Suter L; Brune M; Sorg C
    Cancer Immunol Immunother; 1987; 25(2):81-6. PubMed ID: 3664532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological features of value in differentiating small congenital melanocytic naevi from acquired naevi.
    Walsh MY; MacKie RM
    Histopathology; 1988 Feb; 12(2):145-54. PubMed ID: 3366433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
    Pluot M; Joundi A; Grosshans E
    Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KP1 (CD 68) staining of malignant melanomas.
    Facchetti F; Bertalot G; Grigolato PG
    Histopathology; 1991 Aug; 19(2):141-5. PubMed ID: 1757067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues.
    Hussein MR
    J Clin Pathol; 2005 May; 58(5):453-6. PubMed ID: 15858113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naevus-associated melanomas: cause or chance?
    Massi D; Carli P; Franchi A; Santucci M
    Melanoma Res; 1999 Feb; 9(1):85-91. PubMed ID: 10338338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.